Why the study?
Does TAVI with the Medtronic-Corevalve bioprosthesis improve the incidence of prosthesis-patient mismatch compared to AVR with conventional open stented bioprostheses?
Does TAVI with the Medtronic-Corevalve bioprosthesis improve the incidence of prosthesis-patient mismatch compared to AVR with conventional open stented bioprostheses?
Answers are grounded in this paper and cite their sources.
TAVI with the Corevalve bioprosthesis may offer a favorable profile regarding prosthesis-patient mismatch compared to conventional surgical AVR, with device positioning playing a key role.
The incidence of P-PM following TAVI with the Corevalve bioprosthesis is compared favourably with that seen after AVR with conventional open stented bioprostheses and its occurrence is influenced by device positioning.
No takes yet. Share an insight, caveat, or question.
Jilaihawi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: